Literature DB >> 23932860

Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study.

Michael O Harhay1, Russell P Tracy, Emilia Bagiella, R Graham Barr, Diane Pinder, W Gregory Hundley, David A Bluemke, Richard A Kronmal, Joao A C Lima, Steven M Kawut.   

Abstract

BACKGROUND/
OBJECTIVES: Inflammation contributes to the pathogenesis of disease associated with the left ventricle (LV); yet, our understanding of the effect of inflammation on the right ventricle (RV) is quite limited. METHODS AND
RESULTS: The relationships of C-reactive protein (CRP), interleukin-6 (IL-6) and fibrinogen with RV morphology and function (from cardiac MRI) were examined in participants free of clinical cardiovascular disease (n=4009) from the Multi-Ethnic Study of Atherosclerosis (MESA)-RV study. Multivariable regressions (linear, quantile [25th and 75th] and generalized additive models [GAM]) were used to examine the independent association of CRP, IL-6 and fibrinogen with RV mass, RV end-diastolic volume (RVEDV), RV end-systolic volume (RVESV), RV stroke volume (RVSV) and RV ejection fraction (RVEF). Unadjusted and adjusted analyses revealed strong inverse associations between both CRP and IL-6 with RV mass, RVEDV, RVESV and RVSV (all p<0.01); there were no associations with RVEF. These relationships remained significant after adjustment for the respective LV parameters and lung function. However, GAM models suggested that extreme values of CRP and IL-6 might have positive associations with RV parameters. Fibrinogen showed significant associations in unadjusted models, but no associations after adjustment or in sensitivity analyses.
CONCLUSION: Levels of CRP and IL-6 are independently associated with RV morphology even after adjustment for the respective LV measure in this multi-ethnic population free of clinical cardiovascular disease. Systemic inflammation may contribute to RV structural changes independent of effects on the LV.
© 2013.

Entities:  

Keywords:  Heart failure; Multi-Ethnic Study of Atherosclerosis; Right ventricle; Systemic inflammation

Mesh:

Substances:

Year:  2013        PMID: 23932860      PMCID: PMC3805818          DOI: 10.1016/j.ijcard.2013.06.028

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  43 in total

1.  Age-related inflammatory cytokines and disease.

Authors:  Helle Brüünsgaard; Bente Klarlund Pedersen
Journal:  Immunol Allergy Clin North Am       Date:  2003-02       Impact factor: 3.479

Review 2.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

3.  Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension.

Authors:  Costas Tsioufis; Pavlos Stougiannos; Apostolis Kakkavas; Marina Toutouza; Argiris Mariolis; Ioannis Vlasseros; Christodoulos Stefanadis; Ioannis Kallikazaros
Journal:  Am J Cardiol       Date:  2005-07-15       Impact factor: 2.778

4.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Authors:  A D Pradhan; J E Manson; N Rifai; J E Buring; P M Ridker
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

5.  Laboratory methods and quality assurance in the Cardiovascular Health Study.

Authors:  M Cushman; E S Cornell; P R Howard; E G Bovill; R P Tracy
Journal:  Clin Chem       Date:  1995-02       Impact factor: 8.327

Review 6.  Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role.

Authors:  Senthil Kumar Venugopal; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-01       Impact factor: 2.894

7.  The kidney as a second site of human C-reactive protein formation in vivo.

Authors:  Wolfram J Jabs; Birgit A Lögering; Peter Gerke; Burkhard Kreft; Eva-Maria Wolber; Matthias Heinrich Friedrich Klinger; Lutz Fricke; Jürgen Steinhoff
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

Review 8.  The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.

Authors:  Nada Kherbeck; Mathieu C Tamby; Guillaume Bussone; Hanadi Dib; Frederic Perros; Marc Humbert; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

9.  C-reactive protein decreases prostacyclin release from human aortic endothelial cells.

Authors:  Senthil Kumar Venugopal; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

10.  Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

Authors:  M Humbert; G Monti; F Brenot; O Sitbon; A Portier; L Grangeot-Keros; P Duroux; P Galanaud; G Simonneau; D Emilie
Journal:  Am J Respir Crit Care Med       Date:  1995-05       Impact factor: 21.405

View more
  23 in total

1.  Right Ventricular Structure and Function Are Associated With Incident Atrial Fibrillation: MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle).

Authors:  Neal A Chatterjee; Ravi V Shah; Venkatesh L Murthy; Amy Praestgaard; Sanjiv J Shah; Corey E Ventetuolo; R Graham Barr; Richard Kronmal; Joao A C Lima; David A Bluemke; Michael Jerosch-Herold; Alvaro Alonso; Steven M Kawut
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-01

2.  H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study.

Authors:  Peter J Leary; R Graham Barr; David A Bluemke; Michael R Bristow; Richard A Kronmal; Joao A Lima; David D Ralph; Corey E Ventetuolo; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2014-11

3.  Portal congestion and intestinal edema in hospitalized patients with heart failure.

Authors:  Yuki Ikeda; Shunsuke Ishii; Mayu Yazaki; Teppei Fujita; Yuichiro Iida; Toyoji Kaida; Takeru Nabeta; Eiji Nakatani; Emi Maekawa; Tomoyoshi Yanagisawa; Toshimi Koitabashi; Takayuki Inomata; Junya Ako
Journal:  Heart Vessels       Date:  2018-01-11       Impact factor: 2.037

4.  Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Ravi V Shah; Amanda Anderson; Jingzhong Ding; Matthew Budoff; Oliver Rider; Steffen E Petersen; Majken Karoline Jensen; Manja Koch; Matthew Allison; Nadine Kawel-Boehm; Jessica Wisocky; Michael Jerosch-Herold; Kenneth Mukamal; João A C Lima; Venkatesh L Murthy
Journal:  JACC Cardiovasc Imaging       Date:  2017-03-15

5.  Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study.

Authors:  Steven M Kawut; Hooman D Poor; Megha A Parikh; Katja Hueper; Benjamin M Smith; David A Bluemke; João A C Lima; Martin R Prince; Eric A Hoffman; John H M Austin; Jens Vogel-Claussen; R Graham Barr
Journal:  J Am Coll Cardiol       Date:  2014-11-03       Impact factor: 24.094

6.  The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mahmoud Al Rifai; Andrew P DeFilippis; John W McEvoy; Michael E Hall; Ana Navas Acien; Miranda R Jones; Rachel Keith; Hoda S Magid; Carlos J Rodriguez; Graham R Barr; Emelia J Benjamin; Rose Marie Robertson; Aruni Bhatnagar; Michael J Blaha
Journal:  Atherosclerosis       Date:  2017-01-19       Impact factor: 5.162

7.  Pentraxin-3 and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study.

Authors:  Peter J Leary; Nancy S Jenny; R Graham Barr; David A Bluemke; Michael O Harhay; Susan R Heckbert; Richard A Kronmal; João A Lima; Carmen Mikacenic; Russell P Tracy; Steven M Kawut
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

8.  The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after >10 years of follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Miguel Cainzos-Achirica; Michael D Miedema; John W McEvoy; Mary Cushman; Zeina Dardari; Philip Greenland; Khurram Nasir; Matthew J Budoff; Mouaz H Al-Mallah; Joseph Yeboah; Roger S Blumenthal; Josep Comin-Colet; Michael J Blaha
Journal:  Int J Cardiol       Date:  2018-08-01       Impact factor: 4.164

9.  Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension.

Authors:  Kurt W Prins; Stephen L Archer; Marc Pritzker; Lauren Rose; E Kenneth Weir; Alok Sharma; Thenappan Thenappan
Journal:  J Heart Lung Transplant       Date:  2017-09-01       Impact factor: 10.247

Review 10.  Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.

Authors:  Erik Tandberg Askevold; Lars Gullestad; Christen P Dahl; Arne Yndestad; Thor Ueland; Pål Aukrust
Journal:  Curr Heart Fail Rep       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.